{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:14:33Z","timestamp":1790784873967,"version":"4.1.0"},"reference-count":159,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,11,16]],"date-time":"2015-11-16T00:00:00Z","timestamp":1447632000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Immunol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1038\/nri3919","type":"journal-article","created":{"date-parts":[[2015,11,16]],"date-time":"2015-11-16T05:27:13Z","timestamp":1447651633000},"page":"771-783","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":300,"title":["IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction"],"prefix":"10.1038","volume":"15","author":[{"given":"Bana","family":"Jabri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Abadie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,16]]},"reference":[{"key":"BFnri3919_CR1","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1084\/jem.189.8.1315","volume":"189","author":"LP Cousens","year":"1999","unstructured":"Cousens, L. P. et al. Two roads diverged: interferon \u03b1\/\u03b2- and interleukin 12-mediated pathways in promoting T cell interferon \u03b3 responses during viral infection. J. Exp. Med. 189, 1315\u20131328 (1999).","journal-title":"J. Exp. Med."},{"key":"BFnri3919_CR2","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.micinf.2007.09.004","volume":"9","author":"GA Taylor","year":"2007","unstructured":"Taylor, G. A., Feng, C. G. & Sher, A. Control of IFN-\u03b3-mediated host resistance to intracellular pathogens by immunity-related GTPases (p47 GTPases). Microbes Infect. 9, 1644\u20131651 (2007).","journal-title":"Microbes Infect."},{"key":"BFnri3919_CR3","doi-asserted-by":"publisher","first-page":"5841","DOI":"10.4049\/jimmunol.1201679","volume":"189","author":"L Valentine","year":"2012","unstructured":"Valentine, L., Potts, R. & Premenko-Lanier, M. CD8+ T cell-derived IFN-\u03b3 prevents infection by a second heterologous virus. J. Immunol. 189, 5841\u20135848 (2012).","journal-title":"J. Immunol."},{"key":"BFnri3919_CR4","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","volume":"14","author":"A Antonelli","year":"2015","unstructured":"Antonelli, A., Ferrari, S. M., Corrado, A., Di Domenicantonio, A. & Fallahi, P. Autoimmune thyroid disorders. Autoimmun. Rev. 14, 174\u2013180 (2015).","journal-title":"Autoimmun. Rev."},{"key":"BFnri3919_CR5","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/nri2670","volume":"9","author":"B Jabri","year":"2009","unstructured":"Jabri, B. & Sollid, L. M. Tissue-mediated control of immunopathology in coeliac disease. Nat. Rev. Immunol. 9, 858\u2013870 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnri3919_CR6","doi-asserted-by":"publisher","unstructured":"Walker, L. S. & von Herrath, M. CD4 T cell differentiation in type 1 diabetes. Clin. Exp. Immunol. http:\/\/dx.doi.org\/10.1111\/cei.12672 (2015).","DOI":"10.1111\/cei.12672"},{"key":"BFnri3919_CR7","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nri2580","volume":"9","author":"Y Rochman","year":"2009","unstructured":"Rochman, Y., Spolski, R. & Leonard, W. J. New insights into the regulation of T cells by \u03b3c family cytokines. Nat. Rev. Immunol. 9, 480\u2013490 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnri3919_CR8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nri1901","volume":"6","author":"TA Waldmann","year":"2006","unstructured":"Waldmann, T. A. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat. Rev. Immunol. 6, 595\u2013601 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnri3919_CR9","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1182\/blood-2011-10-384362","volume":"120","author":"C Bergamaschi","year":"2012","unstructured":"Bergamaschi, C. et al. Circulating IL-15 exists as heterodimeric complex with soluble IL-15R\u03b1 in human and mouse serum. Blood 120, e1\u2013e8 (2012).","journal-title":"Blood"},{"key":"BFnri3919_CR10","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1084\/jem.20071913","volume":"205","author":"E Mortier","year":"2008","unstructured":"Mortier, E., Woo, T., Advincula, R., Gozalo, S. & Ma, A. IL-15R\u03b1 chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation. J. Exp. Med. 205, 1213\u20131225 (2008).","journal-title":"J. Exp. Med."},{"key":"BFnri3919_CR11","doi-asserted-by":"publisher","first-page":"6041","DOI":"10.4049\/jimmunol.0901834","volume":"185","author":"N Ota","year":"2010","unstructured":"Ota, N., Takase, M., Uchiyama, H., Olsen, S. K. & Kanagawa, O. No requirement of trans presentations of IL-15 for human CD8 T cell proliferation. J. Immunol. 185, 6041\u20136048 (2010).","journal-title":"J. Immunol."},{"key":"BFnri3919_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.immuni.2013.01.004","volume":"38","author":"W Liao","year":"2013","unstructured":"Liao, W., Lin, J. X. & Leonard, W. J. Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity 38, 13\u201325 (2013).","journal-title":"Immunity"},{"key":"BFnri3919_CR13","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/nm.2365","volume":"17","author":"SC Wuest","year":"2011","unstructured":"Wuest, S. C. et al. A role for interleukin-2 trans-presentation in dendritic cell-mediated T cell activation in humans, as revealed by daclizumab therapy. Nat. Med. 17, 604\u2013609 (2011).","journal-title":"Nat. Med."},{"key":"BFnri3919_CR14","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1158\/1078-0432.CCR-12-3603","volume":"20","author":"A Mishra","year":"2014","unstructured":"Mishra, A., Sullivan, L. & Caligiuri, M. A. Molecular pathways: interleukin-15 signaling in health and in cancer. Clin. Cancer Res. 20, 2044\u20132050 (2014).","journal-title":"Clin. Cancer Res."},{"key":"BFnri3919_CR15","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.4049\/jimmunol.1103609","volume":"188","author":"SL Colpitts","year":"2012","unstructured":"Colpitts, S. L. et al. Cutting edge: the role of IFN-\u03b1 receptor and MyD88 signaling in induction of IL-15 expression in vivo. J. Immunol. 188, 2483\u20132487 (2012).","journal-title":"J. Immunol."},{"key":"BFnri3919_CR16","doi-asserted-by":"publisher","first-page":"7512","DOI":"10.1073\/pnas.0700822104","volume":"104","author":"R Zhou","year":"2007","unstructured":"Zhou, R., Wei, H., Sun, R., Zhang, J. & Tian, Z. NKG2D recognition mediates Toll-like receptor 3 signaling-induced breakdown of epithelial homeostasis in the small intestines of mice. Proc. Natl Acad. Sci. USA 104, 7512\u20137515 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri3919_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/imr.12191","volume":"260","author":"V Abadie","year":"2014","unstructured":"Abadie, V. & Jabri, B. IL-15: a central regulator of celiac disease immunopathology. Immunol. Rev. 260, 221\u2013234 (2014).","journal-title":"Immunol. Rev."},{"key":"BFnri3919_CR18","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1038\/jidsymp.2013.8","volume":"16","author":"TA Waldmann","year":"2013","unstructured":"Waldmann, T. A. The biology of IL-15: implications for cancer therapy and the treatment of autoimmune disorders. J. Investig. Dermatol. Symp. Proc. 16, S28\u2013S30 (2013).","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"BFnri3919_CR19","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1002\/1529-0131(199907)42:7<1508::AID-ANR26>3.0.CO;2-L","volume":"42","author":"S Harada","year":"1999","unstructured":"Harada, S. et al. Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum. 42, 1508\u20131516 (1999).","journal-title":"Arthritis Rheum."},{"key":"BFnri3919_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nm0296-175","volume":"2","author":"IB McInnes","year":"1996","unstructured":"McInnes, I. B. et al. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat. Med. 2, 175\u2013182 (1996).","journal-title":"Nat. Med."},{"key":"BFnri3919_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jneuroim.2008.01.016","volume":"195","author":"A Vaknin-Dembinsky","year":"2008","unstructured":"Vaknin-Dembinsky, A., Brass, S. D., Gandhi, R. & Weiner, H. L. Membrane bound IL-15 is increased on CD14 monocytes in early stages of MS. J. Neuroimmunol. 195, 135\u2013139 (2008).","journal-title":"J. Neuroimmunol."},{"key":"BFnri3919_CR22","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1084\/jem.20130291","volume":"210","author":"G Bouchaud","year":"2013","unstructured":"Bouchaud, G. et al. Epidermal IL-15R\u03b1 acts as an endogenous antagonist of psoriasiform inflammation in mouse and man. J. Exp. Med. 210, 2105\u20132117 (2013).","journal-title":"J. Exp. Med."},{"key":"BFnri3919_CR23","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1172\/JCI200318986","volume":"112","author":"LS Villadsen","year":"2003","unstructured":"Villadsen, L. S. et al. Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model. J. Clin. Invest. 112, 1571\u20131580 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFnri3919_CR24","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1093\/rheumatology\/40.8.876","volume":"40","author":"M Aringer","year":"2001","unstructured":"Aringer, M. et al. Serum interleukin-15 is elevated in systemic lupus erythematosus. Rheumatology (Oxford) 40, 876\u2013881 (2001).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnri3919_CR25","first-page":"364","volume":"13","author":"E Robak","year":"2002","unstructured":"Robak, E. et al. Proinflammatory interferon-gamma-inducing monokines (interleukin-12, interleukin-18, interleukin-15)\u2014serum profile in patients with systemic lupus erythematosus. Eur. Cytokine Netw. 13, 364\u2013368 (2002).","journal-title":"Eur. Cytokine Netw."},{"key":"BFnri3919_CR26","doi-asserted-by":"publisher","first-page":"13534","DOI":"10.1073\/pnas.1312911110","volume":"110","author":"J Chen","year":"2013","unstructured":"Chen, J. et al. Insulin-dependent diabetes induced by pancreatic \u03b2 cell expression of IL-15 and IL-15R\u03b1. Proc. Natl Acad. Sci. USA 110, 13534\u201313539 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri3919_CR27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0092-8674(93)80067-O","volume":"75","author":"B Sadlack","year":"1993","unstructured":"Sadlack, B. et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75, 253\u2013261 (1993).","journal-title":"Cell"},{"key":"BFnri3919_CR28","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/1074-7613(95)90180-9","volume":"3","author":"DM Willerford","year":"1995","unstructured":"Willerford, D. M. et al. Interleukin-2 receptor \u03b1 chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3, 521\u2013530 (1995).","journal-title":"Immunity"},{"key":"BFnri3919_CR29","doi-asserted-by":"publisher","first-page":"228ra37","DOI":"10.1126\/scitranslmed.3007240","volume":"6","author":"B Mlecnik","year":"2014","unstructured":"Mlecnik, B. et al. Functional network pipeline reveals genetic determinants associated with in situ lymphocyte proliferation and survival of cancer patients. Sci. Transl Med. 6, 228ra37 (2014).","journal-title":"Sci. Transl Med."},{"key":"BFnri3919_CR30","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s11894-010-0148-6","volume":"12","author":"BS Sheridan","year":"2010","unstructured":"Sheridan, B. S. & Lefrancois, L. Intraepithelial lymphocytes: to serve and protect. Curr. Gastroenterol. Rep. 12, 513\u2013521 (2010).","journal-title":"Curr. Gastroenterol. Rep."},{"key":"BFnri3919_CR31","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S0167-5699(99)01547-9","volume":"20","author":"P Kalinski","year":"1999","unstructured":"Kalinski, P., Hilkens, C. M., Wierenga, E. A. & Kapsenberg, M. L. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol. Today 20, 561\u2013567 (1999).","journal-title":"Immunol. Today"},{"key":"BFnri3919_CR32","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/mi.2008.27","volume":"1","author":"JV Forrester","year":"2008","unstructured":"Forrester, J. V., Xu, H., Lambe, T. & Cornall, R. Immune privilege or privileged immunity? Mucosal Immunol. 1, 372\u2013381 (2008).","journal-title":"Mucosal Immunol."},{"key":"BFnri3919_CR33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1600-065X.2006.00434.x","volume":"213","author":"E Simpson","year":"2006","unstructured":"Simpson, E. A historical perspective on immunological privilege. Immunol. Rev. 213, 12\u201322 (2006).","journal-title":"Immunol. Rev."},{"key":"BFnri3919_CR34","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1385\/IR:29:1-3:103","volume":"29","author":"KC McKenna","year":"2004","unstructured":"McKenna, K. C. & Kapp, J. A. Ocular immune privilege and CTL tolerance. Immunol. Res. 29, 103\u2013112 (2004).","journal-title":"Immunol. Res."},{"key":"BFnri3919_CR35","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nri2660","volume":"9","author":"CT Weaver","year":"2009","unstructured":"Weaver, C. T. & Hatton, R. D. Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective. Nat. Rev. Immunol. 9, 883\u2013889 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnri3919_CR36","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.immuni.2004.08.011","volume":"21","author":"M Iwata","year":"2004","unstructured":"Iwata, M. et al. Retinoic acid imprints gut-homing specificity on T cells. Immunity 21, 527\u2013538 (2004).","journal-title":"Immunity"},{"key":"BFnri3919_CR37","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1084\/jem.20051100","volume":"202","author":"B Johansson-Lindbom","year":"2005","unstructured":"Johansson-Lindbom, B. et al. Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing. J. Exp. Med. 202, 1063\u20131073 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnri3919_CR38","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nature01726","volume":"424","author":"JR Mora","year":"2003","unstructured":"Mora, J. R. et al. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 424, 88\u201393 (2003).","journal-title":"Nature"},{"key":"BFnri3919_CR39","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1084\/jem.20070590","volume":"204","author":"JL Coombes","year":"2007","unstructured":"Coombes, J. L. et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-\u03b2 and retinoic acid-dependent mechanism. J. Exp. Med. 204, 1757\u20131764 (2007).","journal-title":"J. Exp. Med."},{"key":"BFnri3919_CR40","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1126\/science.1145697","volume":"317","author":"D Mucida","year":"2007","unstructured":"Mucida, D. et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317, 256\u2013260 (2007).","journal-title":"Science"},{"key":"BFnri3919_CR41","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1084\/jem.20070602","volume":"204","author":"CM Sun","year":"2007","unstructured":"Sun, C. M. et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204, 1775\u20131785 (2007).","journal-title":"J. Exp. Med."},{"key":"BFnri3919_CR42","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235\u2013238 (2006).","journal-title":"Nature"},{"key":"BFnri3919_CR43","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1084\/jem.20112339","volume":"209","author":"RW DePaolo","year":"2012","unstructured":"DePaolo, R. W. et al. A specific role for TLR1 in protective TH17 immunity during mucosal infection. J. Exp. Med. 209, 1437\u20131444 (2012).","journal-title":"J. Exp. Med."},{"key":"BFnri3919_CR44","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.immuni.2014.12.007","volume":"41","author":"JM Schenkel","year":"2014","unstructured":"Schenkel, J. M. & Masopust, D. Tissue-resident memory T cells. Immunity 41, 886\u2013897 (2014).","journal-title":"Immunity"},{"key":"BFnri3919_CR45","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.it.2015.05.003","volume":"36","author":"JJ Thome","year":"2015","unstructured":"Thome, J. J. & Farber, D. L. Emerging concepts in tissue-resident T cells: lessons from humans. Trends Immunol. 36, 428\u2013435 (2015).","journal-title":"Trends Immunol."},{"key":"BFnri3919_CR46","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.4049\/jimmunol.1201620","volume":"190","author":"P Deshpande","year":"2013","unstructured":"Deshpande, P. et al. IL-7- and IL-15-mediated TCR sensitization enables T cell responses to self-antigens. J. Immunol. 190, 1416\u20131423 (2013).","journal-title":"J. Immunol."},{"key":"BFnri3919_CR47","doi-asserted-by":"publisher","first-page":"8158","DOI":"10.1073\/pnas.1301022110","volume":"110","author":"RB Liu","year":"2013","unstructured":"Liu, R. B. et al. IL-15 in tumor microenvironment causes rejection of large established tumors by T cells in a noncognate T cell receptor-dependent manner. Proc. Natl Acad. Sci. USA 110, 8158\u20138163 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri3919_CR48","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.4049\/jimmunol.167.10.5527","volume":"167","author":"AI Roberts","year":"2001","unstructured":"Roberts, A. I. et al. NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment. J. Immunol. 167, 5527\u20135530 (2001).","journal-title":"J. Immunol."},{"key":"BFnri3919_CR49","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/nm1176","volume":"11","author":"KS Lang","year":"2005","unstructured":"Lang, K. S. et al. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat. Med. 11, 138\u2013145 (2005).","journal-title":"Nat. Med."},{"key":"BFnri3919_CR50","doi-asserted-by":"publisher","first-page":"7440","DOI":"10.4049\/jimmunol.0900233","volume":"182","author":"AL de Kauwe","year":"2009","unstructured":"de Kauwe, A. L. et al. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells. J. Immunol. 182, 7440\u20137450 (2009).","journal-title":"J. Immunol."},{"key":"BFnri3919_CR51","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nature09849","volume":"471","author":"RW DePaolo","year":"2011","unstructured":"DePaolo, R. W. et al. Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature 471, 220\u2013224 (2011).","journal-title":"Nature"},{"key":"BFnri3919_CR52","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.4049\/jimmunol.163.8.4125","volume":"163","author":"SK Kim","year":"1999","unstructured":"Kim, S. K., Schluns, K. S. & Lefrancois, L. Induction and visualization of mucosal memory CD8 T cells following systemic virus infection. J. Immunol. 163, 4125\u20134132 (1999).","journal-title":"J. Immunol."},{"key":"BFnri3919_CR53","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1172\/JCI200421055","volume":"114","author":"E Marietta","year":"2004","unstructured":"Marietta, E. et al. A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice. J. Clin. Invest. 114, 1090\u20131097 (2004).","journal-title":"J. Clin. Invest."},{"key":"BFnri3919_CR54","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/MPG.0b013e31821a23d0","volume":"54","author":"S Husby","year":"2012","unstructured":"Husby, S. et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J. Pediatr. Gastroenterol. Nutr. 54, 136\u2013160 (2012).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"BFnri3919_CR55","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1053\/j.gastro.2015.05.013","volume":"149","author":"M Setty","year":"2015","unstructured":"Setty, M. et al. Distinct and synergistic contributions of epithelial stress and adaptive immunity to functions of intraepithelial killer cells and active celiac disease. Gastroenterology 149, 681\u2013691 (2015).","journal-title":"Gastroenterology"},{"key":"BFnri3919_CR56","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.clim.2013.02.005","volume":"149","author":"SA Long","year":"2013","unstructured":"Long, S. A., Buckner, J. H. & Greenbaum, C. J. IL-2 therapy in type 1 diabetes: \u201cTrials\u201d and tribulations. Clin. Immunol. 149, 324\u2013331 (2013).","journal-title":"Clin. Immunol."},{"key":"BFnri3919_CR57","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/ni.2449","volume":"13","author":"AM Ring","year":"2012","unstructured":"Ring, A. M. et al. Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15. Nat. Immunol. 13, 1187\u20131195 (2012).","journal-title":"Nat. Immunol."},{"key":"BFnri3919_CR58","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1084\/jem.191.5.771","volume":"191","author":"MK Kennedy","year":"2000","unstructured":"Kennedy, M. K. et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191, 771\u2013780 (2000).","journal-title":"J. Exp. Med."},{"key":"BFnri3919_CR59","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1002\/eji.200737607","volume":"38","author":"H Imamichi","year":"2008","unstructured":"Imamichi, H., Sereti, I. & Lane, H. C. IL-15 acts as a potent inducer of CD4+CD25hi cells expressing FOXP3. Eur. J. Immunol. 38, 1621\u20131630 (2008).","journal-title":"Eur. J. Immunol."},{"key":"BFnri3919_CR60","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s12026-014-8488-1","volume":"60","author":"SJ Lin","year":"2014","unstructured":"Lin, S. J. et al. Expansion of regulatory T cells from umbilical cord blood and adult peripheral blood CD4+CD25+ T cells. Immunol. Res. 60, 105\u2013111 (2014).","journal-title":"Immunol. Res."},{"key":"BFnri3919_CR61","doi-asserted-by":"publisher","first-page":"5282","DOI":"10.4049\/jimmunol.1402827","volume":"194","author":"NH Litjens","year":"2015","unstructured":"Litjens, N. H. et al. Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15. J. Immunol. 194, 5282\u20135293 (2015).","journal-title":"J. Immunol."},{"key":"BFnri3919_CR62","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.4049\/jimmunol.1402144","volume":"193","author":"D Marshall","year":"2014","unstructured":"Marshall, D., Sinclair, C., Tung, S. & Seddon, B. Differential requirement for IL-2 and IL-15 during bifurcated development of thymic regulatory T cells. J. Immunol. 193, 5525\u20135533 (2014).","journal-title":"J. Immunol."},{"key":"BFnri3919_CR63","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3389\/fimmu.2013.00161","volume":"4","author":"J Raynor","year":"2013","unstructured":"Raynor, J. et al. IL-15 fosters age-driven regulatory T cell accrual in the face of declining IL-2 levels. Front. Immunol. 4, 161 (2013).","journal-title":"Front. Immunol."},{"key":"BFnri3919_CR64","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/ni1264","volume":"6","author":"LM D'Cruz","year":"2005","unstructured":"D'Cruz, L. M. & Klein, L. Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling. Nat. Immunol. 6, 1152\u20131159 (2005).","journal-title":"Nat. Immunol."},{"key":"BFnri3919_CR65","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/ni1263","volume":"6","author":"JD Fontenot","year":"2005","unstructured":"Fontenot, J. D., Rasmussen, J. P., Gavin, M. A. & Rudensky, A. Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6, 1142\u20131151 (2005).","journal-title":"Nat. Immunol."},{"key":"BFnri3919_CR66","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/ni1105-1071","volume":"6","author":"KJ Maloy","year":"2005","unstructured":"Maloy, K. J. & Powrie, F. Fueling regulation: IL-2 keeps CD4+ Treg cells fit. Nat. Immunol. 6, 1071\u20131072 (2005).","journal-title":"Nat. Immunol."},{"key":"BFnri3919_CR67","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev.immunol.17.1.221","volume":"17","author":"M Lenardo","year":"1999","unstructured":"Lenardo, M. et al. Mature T lymphocyte apoptosis\u2014immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 17, 221\u2013253 (1999).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnri3919_CR68","doi-asserted-by":"publisher","first-page":"460","DOI":"10.4049\/jimmunol.169.1.460","volume":"169","author":"N Ohta","year":"2002","unstructured":"Ohta, N. et al. IL-15-dependent activation-induced cell death-resistant Th1 type CD8 \u03b1\u03b2+NK1.1+ T cells for the development of small intestinal inflammation. J. Immunol. 169, 460\u2013468 (2002).","journal-title":"J. Immunol."},{"key":"BFnri3919_CR69","first-page":"105","volume":"14","author":"TA Waldmann","year":"2001","unstructured":"Waldmann, T. A., Dubois, S. & Tagaya, Y. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Immunity 14, 105\u2013110 (2001).","journal-title":"Immunity"},{"key":"BFnri3919_CR70","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1126\/science.288.5466.675","volume":"288","author":"CC Ku","year":"2000","unstructured":"Ku, C. C., Murakami, M., Sakamoto, A., Kappler, J. & Marrack, P. Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science 288, 675\u2013678 (2000).","journal-title":"Science"},{"key":"BFnri3919_CR71","doi-asserted-by":"publisher","first-page":"4724","DOI":"10.1073\/pnas.0737048100","volume":"100","author":"PR Burkett","year":"2003","unstructured":"Burkett, P. R. et al. IL-15R\u03b1 expression on CD8+ T cells is dispensable for T cell memory. Proc. Natl Acad. Sci. USA 100, 4724\u20134729 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri3919_CR72","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S1074-7613(02)00429-6","volume":"17","author":"S Dubois","year":"2002","unstructured":"Dubois, S., Mariner, J., Waldmann, T. A. & Tagaya, Y. IL-15R\u03b1 recycles and presents IL-15 in trans to neighboring cells. Immunity 17, 537\u2013547 (2002).","journal-title":"Immunity"},{"key":"BFnri3919_CR73","doi-asserted-by":"publisher","first-page":"6763","DOI":"10.4049\/jimmunol.0801792","volume":"182","author":"M Ben Ahmed","year":"2009","unstructured":"Ben Ahmed, M. et al. IL-15 renders conventional lymphocytes resistant to suppressive functions of regulatory T cells through activation of the phosphatidylinositol 3-kinase pathway. J. Immunol. 182, 6763\u20136770 (2009).","journal-title":"J. Immunol."},{"key":"BFnri3919_CR74","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1084\/jem.20050085","volume":"201","author":"CR Ruprecht","year":"2005","unstructured":"Ruprecht, C. R. et al. Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. J. Exp. Med. 201, 1793\u20131803 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnri3919_CR75","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S0016-5085(00)70173-9","volume":"118","author":"B Jabri","year":"2000","unstructured":"Jabri, B. et al. Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease. Gastroenterology 118, 867\u2013879 (2000).","journal-title":"Gastroenterology"},{"key":"BFnri3919_CR76","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S0016-5085(03)01047-3","volume":"125","author":"JJ Mention","year":"2003","unstructured":"Mention, J. J. et al. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 125, 730\u2013745 (2003).","journal-title":"Gastroenterology"},{"key":"BFnri3919_CR77","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.immuni.2013.02.010","volume":"38","author":"A Fuchs","year":"2013","unstructured":"Fuchs, A. et al. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-\u03b3-producing cells. Immunity 38, 769\u2013781 (2013).","journal-title":"Immunity"},{"key":"BFnri3919_CR78","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1073\/pnas.1318281111","volume":"111","author":"G Cui","year":"2014","unstructured":"Cui, G. et al. Characterization of the IL-15 niche in primary and secondary lymphoid organs in vivo. Proc. Natl Acad. Sci. USA 111, 1915\u20131920 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri3919_CR79","doi-asserted-by":"crossref","first-page":"735","DOI":"10.4049\/jimmunol.156.2.735","volume":"156","author":"TM Doherty","year":"1996","unstructured":"Doherty, T. M., Seder, R. A. & Sher, A. Induction and regulation of IL-15 expression in murine macrophages. J. Immunol. 156, 735\u2013741 (1996).","journal-title":"J. Immunol."},{"key":"BFnri3919_CR80","doi-asserted-by":"publisher","first-page":"8662","DOI":"10.1073\/pnas.0503360102","volume":"102","author":"SP Dubois","year":"2005","unstructured":"Dubois, S. P., Waldmann, T. A. & Muller, J. R. Survival adjustment of mature dendritic cells by IL-15. Proc. Natl Acad. Sci. USA 102, 8662\u20138667 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri3919_CR81","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.4049\/jimmunol.167.3.1179","volume":"167","author":"F Mattei","year":"2001","unstructured":"Mattei, F., Schiavoni, G., Belardelli, F. & Tough, D. F. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J. Immunol. 167, 1179\u20131187 (2001).","journal-title":"J. Immunol."},{"key":"BFnri3919_CR82","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/nm1615","volume":"13","author":"Z Orinska","year":"2007","unstructured":"Orinska, Z. et al. IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities. Nat. Med. 13, 927\u2013934 (2007).","journal-title":"Nat. Med."},{"key":"BFnri3919_CR83","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/art.21731","volume":"54","author":"ME Miranda-Carus","year":"2006","unstructured":"Miranda-Carus, M. E. et al. Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promote osteoclastogenesis in autologous monocytes. Arthritis Rheum. 54, 1151\u20131164 (2006).","journal-title":"Arthritis Rheum."},{"key":"BFnri3919_CR84","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.4049\/jimmunol.1100885","volume":"187","author":"R Schneider","year":"2011","unstructured":"Schneider, R. et al. B cell-derived IL-15 enhances CD8 T cell cytotoxicity and is increased in multiple sclerosis patients. J. Immunol. 187, 4119\u20134128 (2011).","journal-title":"J. Immunol."},{"key":"BFnri3919_CR85","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/35636","volume":"391","author":"K Ogasawara","year":"1998","unstructured":"Ogasawara, K. et al. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature 391, 700\u2013703 (1998).","journal-title":"Nature"},{"key":"BFnri3919_CR86","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1046\/j.1523-1747.2001.00239.x","volume":"116","author":"G Rappl","year":"2001","unstructured":"Rappl, G. et al. Dermal fibroblasts sustain proliferation of activated T cells via membrane-bound interleukin-15 upon long-term stimulation with tumor necrosis factor-\u03b1. J. Invest. Dermatol. 116, 102\u2013109 (2001).","journal-title":"J. Invest. Dermatol."},{"key":"BFnri3919_CR87","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.4049\/jimmunol.0900420","volume":"183","author":"LJ Ma","year":"2009","unstructured":"Ma, L. J., Acero, L. F., Zal, T. & Schluns, K. S. Trans-presentation of IL-15 by intestinal epithelial cells drives development of CD8\u03b1\u03b1 IELs. J. Immunol. 183, 1044\u20131054 (2009).","journal-title":"J. Immunol."},{"key":"BFnri3919_CR88","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/S0016-5085(96)70036-7","volume":"111","author":"HC Reinecker","year":"1996","unstructured":"Reinecker, H. C., MacDermott, R. P., Mirau, S., Dignass, A. & Podolsky, D. K. Intestinal epithelial cells both express and respond to interleukin 15. Gastroenterology 111, 1706\u20131713 (1996).","journal-title":"Gastroenterology"},{"key":"BFnri3919_CR89","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1183\/09031936.00099811","volume":"39","author":"MT Zdrenghea","year":"2012","unstructured":"Zdrenghea, M. T. et al. RSV infection modulates IL-15 production and MICA levels in respiratory epithelial cells. Eur. Respir. J. 39, 712\u2013720 (2012).","journal-title":"Eur. Respir. J."},{"key":"BFnri3919_CR90","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/nm.3645","volume":"20","author":"L Xing","year":"2014","unstructured":"Xing, L. et al. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition. Nat. Med. 20, 1043\u20131049 (2014).","journal-title":"Nat. Med."},{"key":"BFnri3919_CR91","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.4049\/jimmunol.165.4.2240","volume":"165","author":"R Ruckert","year":"2000","unstructured":"Ruckert, R. et al. Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis? J. Immunol. 165, 2240\u20132250 (2000).","journal-title":"J. Immunol."},{"key":"BFnri3919_CR92","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1365-3083.2008.02197.x","volume":"69","author":"H Bo","year":"2009","unstructured":"Bo, H. et al. Elevated expression of transmembrane IL-15 in immune cells correlates with the development of murine lupus: a potential target for immunotherapy against SLE. Scand. J. Immunol. 69, 119\u2013129 (2009).","journal-title":"Scand. J. Immunol."},{"key":"BFnri3919_CR93","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1053\/gast.2000.18149","volume":"119","author":"L Maiuri","year":"2000","unstructured":"Maiuri, L. et al. Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology 119, 996\u20131006 (2000).","journal-title":"Gastroenterology"},{"key":"BFnri3919_CR94","first-page":"1789","volume":"91","author":"I Kirman","year":"1996","unstructured":"Kirman, I. & Nielsen, O. H. Increased numbers of interleukin-15-expressing cells in active ulcerative colitis. Am. J. Gastroenterol. 91, 1789\u20131794 (1996).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnri3919_CR95","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.4049\/jimmunol.164.7.3608","volume":"164","author":"Z Liu","year":"2000","unstructured":"Liu, Z. et al. IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production. J. Immunol. 164, 3608\u20133615 (2000).","journal-title":"J. Immunol."},{"key":"BFnri3919_CR96","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1006\/cyto.2000.0744","volume":"12","author":"B Vainer","year":"2000","unstructured":"Vainer, B., Nielsen, O. H., Hendel, J., Horn, T. & Kirman, I. Colonic expression and synthesis of interleukin 13 and interleukin 15 in inflammatory bowel disease. Cytokine 12, 1531\u20131536 (2000).","journal-title":"Cytokine"},{"key":"BFnri3919_CR97","doi-asserted-by":"crossref","first-page":"910","DOI":"10.4049\/jimmunol.157.2.910","volume":"157","author":"C Agostini","year":"1996","unstructured":"Agostini, C. et al. Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J. Immunol. 157, 910\u2013918 (1996).","journal-title":"J. Immunol."},{"key":"BFnri3919_CR98","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1146\/annurev.immunol.17.1.19","volume":"17","author":"TA Waldmann","year":"1999","unstructured":"Waldmann, T. A. & Tagaya, Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu. Rev. Immunol. 17, 19\u201349 (1999).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnri3919_CR99","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/ni729","volume":"2","author":"T Ohteki","year":"2001","unstructured":"Ohteki, T., Suzue, K., Maki, C., Ota, T. & Koyasu, S. Critical role of IL-15\u2013IL-15R for antigen-presenting cell functions in the innate immune response. Nat. Immunol. 2, 1138\u20131143 (2001).","journal-title":"Nat. Immunol."},{"key":"BFnri3919_CR100","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S1995-7645(13)60076-0","volume":"6","author":"X Yu","year":"2013","unstructured":"Yu, X. et al. Artificial antigen-presenting cells plus IL-15 and IL-21 efficiently induce melanoma-specific cytotoxic CD8+ CD28+ T lymphocyte responses. Asian Pac. J. Trop. Med. 6, 467\u2013472 (2013).","journal-title":"Asian Pac. J. Trop. Med."},{"key":"BFnri3919_CR101","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.4161\/hv.25373","volume":"9","author":"S Anguille","year":"2013","unstructured":"Anguille, S. et al. Interleukin-15 dendritic cells as vaccine candidates for cancer immunotherapy. Hum. Vaccin. Immunother. 9, 1956\u20131961 (2013).","journal-title":"Hum. Vaccin. Immunother."},{"key":"BFnri3919_CR102","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.tips.2011.09.004","volume":"33","author":"JC Steel","year":"2012","unstructured":"Steel, J. C., Waldmann, T. A. & Morris, J. C. Interleukin-15 biology and its therapeutic implications in cancer. Trends Pharmacol. Sci. 33, 35\u201341 (2012).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFnri3919_CR103","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.4049\/jimmunol.1201476","volume":"189","author":"P Pandiyan","year":"2012","unstructured":"Pandiyan, P. et al. The role of IL-15 in activating STAT5 and fine-tuning IL-17A production in CD4 T lymphocytes. J. Immunol. 189, 4237\u20134246 (2012).","journal-title":"J. Immunol."},{"key":"BFnri3919_CR104","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.cyto.2012.06.017","volume":"59","author":"EF Castillo","year":"2012","unstructured":"Castillo, E. F. & Schluns, K. S. Regulating the immune system via IL-15 transpresentation. Cytokine 59, 479\u2013490 (2012).","journal-title":"Cytokine"},{"key":"BFnri3919_CR105","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/S0016-5085(98)70022-8","volume":"115","author":"EC Ebert","year":"1998","unstructured":"Ebert, E. C. Interleukin 15 is a potent stimulant of intraepithelial lymphocytes. Gastroenterology 115, 1439\u20131445 (1998).","journal-title":"Gastroenterology"},{"key":"BFnri3919_CR106","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1600-065X.2006.00481.x","volume":"215","author":"B Jabri","year":"2007","unstructured":"Jabri, B. & Ebert, E. Human CD8+ intraepithelial lymphocytes: a unique model to study the regulation of effector cytotoxic T lymphocytes in tissue. Immunol. Rev. 215, 202\u2013214 (2007).","journal-title":"Immunol. Rev."},{"key":"BFnri3919_CR107","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.immuni.2004.06.020","volume":"21","author":"B Meresse","year":"2004","unstructured":"Meresse, B. et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21, 357\u2013366 (2004).","journal-title":"Immunity"},{"key":"BFnri3919_CR108","doi-asserted-by":"publisher","first-page":"231","DOI":"10.4161\/self.1.3.12968","volume":"1","author":"P Riha","year":"2010","unstructured":"Riha, P. & Rudd, C. E. CD28 co-signaling in the adaptive immune response. Self Nonself 1, 231\u2013240 (2010).","journal-title":"Self Nonself"},{"key":"BFnri3919_CR109","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1084\/jem.20071887","volume":"206","author":"F Tang","year":"2009","unstructured":"Tang, F. et al. Cytosolic PLA2 is required for CTL-mediated immunopathology of celiac disease via NKG2D and IL-15. J. Exp. Med. 206, 707\u2013719 (2009).","journal-title":"J. Exp. Med."},{"key":"BFnri3919_CR110","doi-asserted-by":"publisher","first-page":"671","DOI":"10.4049\/jimmunol.168.2.671","volume":"168","author":"CL Sutherland","year":"2002","unstructured":"Sutherland, C. L. et al. UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells. J. Immunol. 168, 671\u2013679 (2002).","journal-title":"J. Immunol."},{"key":"BFnri3919_CR111","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S1074-7613(02)00427-2","volume":"17","author":"B Jabri","year":"2002","unstructured":"Jabri, B. et al. TCR specificity dictates CD94\/NKG2A expression by human CTL. Immunity 17, 487\u2013499 (2002).","journal-title":"Immunity"},{"key":"BFnri3919_CR112","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.immuni.2004.06.018","volume":"21","author":"S Hue","year":"2004","unstructured":"Hue, S. et al. A direct role for NKG2D\/MICA interaction in villous atrophy during celiac disease. Immunity 21, 367\u2013377 (2004).","journal-title":"Immunity"},{"key":"BFnri3919_CR113","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1084\/jem.20060028","volume":"203","author":"B Meresse","year":"2006","unstructured":"Meresse, B. et al. Reprogramming of CTLs into natural killer-like cells in celiac disease. J. Exp. Med. 203, 1343\u20131355 (2006).","journal-title":"J. Exp. Med."},{"key":"BFnri3919_CR114","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1126\/science.285.5428.727","volume":"285","author":"S Bauer","year":"1999","unstructured":"Bauer, S. et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285, 727\u2013729 (1999).","journal-title":"Science"},{"key":"BFnri3919_CR115","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1126\/science.285.5428.730","volume":"285","author":"J Wu","year":"1999","unstructured":"Wu, J. et al. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 285, 730\u2013732 (1999).","journal-title":"Science"},{"key":"BFnri3919_CR116","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/85321","volume":"2","author":"V Groh","year":"2001","unstructured":"Groh, V. et al. Costimulation of CD8\u03b1\u03b2 T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2, 255\u2013260 (2001).","journal-title":"Nat. Immunol."},{"key":"BFnri3919_CR117","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.cell.2014.10.026","volume":"159","author":"JJ Thome","year":"2014","unstructured":"Thome, J. J. et al. Spatial map of human T cell compartmentalization and maintenance over decades of life. Cell 159, 814\u2013828 (2014).","journal-title":"Cell"},{"key":"BFnri3919_CR118","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.cyto.2008.01.003","volume":"42","author":"C Zhang","year":"2008","unstructured":"Zhang, C., Zhang, J., Niu, J. & Tian, Z. Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1\/2 phosphorylation. Cytokine 42, 128\u2013136 (2008).","journal-title":"Cytokine"},{"key":"BFnri3919_CR119","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.smim.2006.03.001","volume":"18","author":"JL Upshaw","year":"2006","unstructured":"Upshaw, J. L. & Leibson, P. J. NKG2D-mediated activation of cytotoxic lymphocytes: unique signaling pathways and distinct functional outcomes. Semin. Immunol. 18, 167\u2013175 (2006).","journal-title":"Semin. Immunol."},{"key":"BFnri3919_CR120","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/83707","volume":"27","author":"RS Wildin","year":"2001","unstructured":"Wildin, R. S. et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27, 18\u201320 (2001).","journal-title":"Nat. Genet."},{"key":"BFnri3919_CR121","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nri2889","volume":"10","author":"JH Buckner","year":"2010","unstructured":"Buckner, J. H. Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases. Nat. Rev. Immunol. 10, 849\u2013859 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnri3919_CR122","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/immu.200390024","volume":"33","author":"D Cao","year":"2003","unstructured":"Cao, D. et al. Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur. J. Immunol. 33, 215\u2013223 (2003).","journal-title":"Eur. J. Immunol."},{"key":"BFnri3919_CR123","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1365-2249.2005.02754.x","volume":"140","author":"M Mottonen","year":"2005","unstructured":"Mottonen, M. et al. CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin. Exp. Immunol. 140, 360\u2013367 (2005).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnri3919_CR124","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1053\/j.gastro.2005.03.043","volume":"128","author":"J Maul","year":"2005","unstructured":"Maul, J. et al. Peripheral and intestinal regulatory CD4+ CD25high T cells in inflammatory bowel disease. Gastroenterology 128, 1868\u20131878 (2005).","journal-title":"Gastroenterology"},{"key":"BFnri3919_CR125","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1365-2249.2007.03566.x","volume":"151","author":"B Sitohy","year":"2008","unstructured":"Sitohy, B., Hammarstrom, S., Danielsson, A. & Hammarstrom, M. L. Basal lymphoid aggregates in ulcerative colitis colon: a site for regulatory T cell action. Clin. Exp. Immunol. 151, 326\u2013333 (2008).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnri3919_CR126","doi-asserted-by":"publisher","first-page":"11445","DOI":"10.1073\/pnas.200363097","volume":"97","author":"J Marks-Konczalik","year":"2000","unstructured":"Marks-Konczalik, J. et al. IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. Proc. Natl Acad. Sci. USA 97, 11445\u201311450 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri3919_CR127","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.0105-2896.2005.00318.x","volume":"207","author":"BN Lilley","year":"2005","unstructured":"Lilley, B. N. & Ploegh, H. L. Viral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond. Immunol. Rev. 207, 126\u2013144 (2005).","journal-title":"Immunol. Rev."},{"key":"BFnri3919_CR128","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1046\/j.1365-3083.1999.00593.x","volume":"50","author":"M Maeurer","year":"1999","unstructured":"Maeurer, M., Seliger, B., Trinder, P., Gerdes, J. & Seitzer, U. Interleukin-15 in mycobacterial infection of antigen-presenting cells. Scand. J. Immunol. 50, 280\u2013288 (1999).","journal-title":"Scand. J. Immunol."},{"key":"BFnri3919_CR129","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1006\/cimm.2000.1644","volume":"202","author":"T Liu","year":"2000","unstructured":"Liu, T., Nishimura, H., Matsuguchi, T. & Yoshikai, Y. Differences in interleukin-12 and -15 production by dendritic cells at the early stage of Listeria monocytogenes infection between BALB\/c and C57 BL\/6 mice. Cell. Immunol. 202, 31\u201340 (2000).","journal-title":"Cell. Immunol."},{"key":"BFnri3919_CR130","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1086\/444393","volume":"192","author":"SM Dann","year":"2005","unstructured":"Dann, S. M. et al. Interleukin-15 activates human natural killer cells to clear the intestinal protozoan Cryptosporidium. J. Infect. Dis. 192, 1294\u20131302 (2005).","journal-title":"J. Infect. Dis."},{"key":"BFnri3919_CR131","doi-asserted-by":"publisher","first-page":"e1004521","DOI":"10.1371\/journal.ppat.1004521","volume":"10","author":"M Braun","year":"2014","unstructured":"Braun, M. et al. NK cell activation in human hantavirus infection explained by virus-induced IL-15\/IL15R\u03b1 expression. PLoS Pathog. 10, e1004521 (2014).","journal-title":"PLoS Pathog."},{"key":"BFnri3919_CR132","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.4049\/jimmunol.163.8.4473","volume":"163","author":"LM Fawaz","year":"1999","unstructured":"Fawaz, L. M., Sharif-Askari, E. & Menezes, J. Up-regulation of NK cytotoxic activity via IL-15 induction by different viruses: a comparative study. J. Immunol. 163, 4473\u20134480 (1999).","journal-title":"J. Immunol."},{"key":"BFnri3919_CR133","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.4049\/jimmunol.178.7.4548","volume":"178","author":"R Zhou","year":"2007","unstructured":"Zhou, R., Wei, H., Sun, R. & Tian, Z. Recognition of double-stranded RNA by TLR3 induces severe small intestinal injury in mice. J. Immunol. 178, 4548\u20134556 (2007).","journal-title":"J. Immunol."},{"key":"BFnri3919_CR134","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1002\/eji.200535290","volume":"36","author":"A Rausch","year":"2006","unstructured":"Rausch, A. et al. Interleukin-15 mediates protection against experimental tuberculosis: a role for NKG2D-dependent effector mechanisms of CD8+ T cells. Eur. J. Immunol. 36, 1156\u20131167 (2006).","journal-title":"Eur. J. Immunol."},{"key":"BFnri3919_CR135","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ibd.20026","volume":"13","author":"L Perera","year":"2007","unstructured":"Perera, L. et al. Expression of nonclassical class I molecules by intestinal epithelial cells. Inflamm. Bowel Dis. 13, 298\u2013307 (2007).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnri3919_CR136","first-page":"121","volume":"298","author":"S Gonzalez","year":"2006","unstructured":"Gonzalez, S., Groh, V. & Spies, T. Immunobiology of human NKG2D and its ligands. Curr. Top. Microbiol. Immunol. 298, 121\u2013138 (2006).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"BFnri3919_CR137","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev-immunol-032712-095951","volume":"31","author":"DH Raulet","year":"2013","unstructured":"Raulet, D. H., Gasser, S., Gowen, B. G., Deng, W. & Jung, H. Regulation of ligands for the NKG2D activating receptor. Annu. Rev. Immunol. 31, 413\u2013441 (2013).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnri3919_CR138","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1182\/blood.V94.12.4210","volume":"94","author":"J Gosselin","year":"1999","unstructured":"Gosselin, J., TomoIu, A., Gallo, R. C. & Flamand, L. Interleukin-15 as an activator of natural killer cell-mediated antiviral response. Blood 94, 4210\u20134219 (1999).","journal-title":"Blood"},{"key":"BFnri3919_CR139","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.4049\/jimmunol.169.8.4279","volume":"169","author":"KB Nguyen","year":"2002","unstructured":"Nguyen, K. B. et al. Coordinated and distinct roles for IFN-\u03b1\u03b2, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169, 4279\u20134287 (2002).","journal-title":"J. Immunol."},{"key":"BFnri3919_CR140","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1093\/jnci\/93.22.1724","volume":"93","author":"E Sharif-Askari","year":"2001","unstructured":"Sharif-Askari, E., Fawaz, L. M., Tran, P., Ahmad, A. & Menezes, J. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein\u2013Barr virus-transformed\/immortalized lymphocytes in culture. J. Natl Cancer Inst. 93, 1724\u20131732 (2001).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnri3919_CR141","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nri2276","volume":"8","author":"LL Lanier","year":"2008","unstructured":"Lanier, L. L. Evolutionary struggles between NK cells and viruses. Nat. Rev. Immunol. 8, 259\u2013268 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnri3919_CR142","first-page":"151","volume":"40","author":"J Losy","year":"2002","unstructured":"Losy, J., Niezgoda, A. & Zaremba, J. IL-15 is elevated in sera of patients with relapsing-remitting multiple sclerosis. Folia Neuropathol. 40, 151\u2013153 (2002).","journal-title":"Folia Neuropathol."},{"key":"BFnri3919_CR143","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1053\/j.gastro.2007.03.025","volume":"132","author":"M Allez","year":"2007","unstructured":"Allez, M. et al. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions. Gastroenterology 132, 2346\u20132358 (2007).","journal-title":"Gastroenterology"},{"key":"BFnri3919_CR144","doi-asserted-by":"publisher","first-page":"9452","DOI":"10.1073\/pnas.1632807100","volume":"100","author":"V Groh","year":"2003","unstructured":"Groh, V., Bruhl, A., El-Gabalawy, H., Nelson, J. L. & Spies, T. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc. Natl Acad. Sci. USA 100, 9452\u20139457 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri3919_CR145","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1002\/art.30355","volume":"63","author":"M de Menthon","year":"2011","unstructured":"de Menthon, M. et al. Excessive interleukin-15 transpresentation endows NKG2D+CD4+ T cells with innate-like capacity to lyse vascular endothelium in granulomatosis with polyangiitis (Wegener's). Arthritis Rheum. 63, 2116\u20132126 (2011).","journal-title":"Arthritis Rheum."},{"key":"BFnri3919_CR146","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.diabres.2005.02.007","volume":"69","author":"S Kuczynski","year":"2005","unstructured":"Kuczynski, S. et al. IL-15 is elevated in serum patients with type 1 diabetes mellitus. Diabetes Res. Clin. Pract. 69, 231\u2013236 (2005).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"BFnri3919_CR147","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1126\/science.1233913","volume":"339","author":"S Malchow","year":"2013","unstructured":"Malchow, S. et al. Aire-dependent thymic development of tumor-associated regulatory T cells. Science 339, 1219\u20131224 (2013).","journal-title":"Science"},{"key":"BFnri3919_CR148","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nm730","volume":"8","author":"H Dong","year":"2002","unstructured":"Dong, H. et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8, 793\u2013800 (2002).","journal-title":"Nat. Med."},{"key":"BFnri3919_CR149","doi-asserted-by":"publisher","first-page":"12293","DOI":"10.1073\/pnas.192461099","volume":"99","author":"Y Iwai","year":"2002","unstructured":"Iwai, Y. et al. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc. Natl Acad. Sci. USA 99, 12293\u201312297 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri3919_CR150","first-page":"1","volume":"344","author":"WH Fridman","year":"2011","unstructured":"Fridman, W. H. et al. Immune infiltration in human cancer: prognostic significance and disease control. Curr. Top. Microbiol. Immunol. 344, 1\u201324 (2011).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"BFnri3919_CR151","doi-asserted-by":"publisher","first-page":"9166","DOI":"10.1073\/pnas.0600240103","volume":"103","author":"MP Rubinstein","year":"2006","unstructured":"Rubinstein, M. P. et al. Converting IL-15 to a superagonist by binding to soluble IL-15R\u03b1. Proc. Natl Acad. Sci. USA 103, 9166\u20139171 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri3919_CR152","doi-asserted-by":"publisher","first-page":"e26442","DOI":"10.4161\/onci.26442","volume":"2","author":"HC Wong","year":"2013","unstructured":"Wong, H. C., Jeng, E. K. & Rhode, P. R. The IL-15-based superagonist ALT-803 promotes the antigen-independent conversion of memory CD8 T cells into innate-like effector cells with antitumor activity. Oncoimmunology 2, e26442 (2013).","journal-title":"Oncoimmunology"},{"key":"BFnri3919_CR153","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/BF01741084","volume":"36","author":"RA Maas","year":"1993","unstructured":"Maas, R. A., Dullens, H. F. & Den Otter, W. Interleukin-2 in cancer treatment: disappointing or (still) promising? A review. Cancer Immunol. Immunother. 36, 141\u2013148 (1993).","journal-title":"Cancer Immunol. Immunother."},{"key":"BFnri3919_CR154","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev.immunol.23.021704.115843","volume":"23","author":"AN Theofilopoulos","year":"2005","unstructured":"Theofilopoulos, A. N., Baccala, R., Beutler, B. & Kono, D. H. Type I interferons \u03b1\/\u03b2 in immunity and autoimmunity. Annu. Rev. Immunol. 23, 307\u2013336 (2005).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnri3919_CR155","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.immuni.2015.07.007","volume":"43","author":"H Hammad","year":"2015","unstructured":"Hammad, H. & Lambrecht, B. N. Barrier epithelial cells and the control of type 2 immunity. Immunity 43, 29\u201340 (2015).","journal-title":"Immunity"},{"key":"BFnri3919_CR156","doi-asserted-by":"publisher","first-page":"4609","DOI":"10.3748\/wjg.15.4609","volume":"15","author":"D De Nitto","year":"2009","unstructured":"De Nitto, D., Monteleone, I., Franze, E., Pallone, F. & Monteleone, G. Involvement of interleukin-15 and interleukin-21, two \u03b3-chain-related cytokines, in celiac disease. World J. Gastroenterol. 15, 4609\u20134614 (2009).","journal-title":"World J. Gastroenterol."},{"key":"BFnri3919_CR157","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev.immunol.26.021607.090316","volume":"26","author":"R Spolski","year":"2008","unstructured":"Spolski, R. & Leonard, W. J. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu. Rev. Immunol. 26, 57\u201379 (2008).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnri3919_CR158","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.4049\/jimmunol.1201730","volume":"190","author":"AP Sutherland","year":"2013","unstructured":"Sutherland, A. P. et al. IL-21 promotes CD8+ CTL activity via the transcription factor T-bet. J. Immunol. 190, 3977\u20133984 (2013).","journal-title":"J. Immunol."},{"key":"BFnri3919_CR159","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1600-065X.1993.tb01516.x","volume":"133","author":"SW Umlauf","year":"1993","unstructured":"Umlauf, S. W. et al. Molecular regulation of the IL-2 gene: rheostatic control of the immune system. Immunol. Rev. 133, 177\u2013197 (1993).","journal-title":"Immunol. Rev."}],"container-title":["Nature Reviews Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nri3919.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nri3919","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nri3919.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T17:37:17Z","timestamp":1692121037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nri3919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,16]]},"references-count":159,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["BFnri3919"],"URL":"https:\/\/doi.org\/10.1038\/nri3919","relation":{},"ISSN":["1474-1733","1474-1741"],"issn-type":[{"value":"1474-1733","type":"print"},{"value":"1474-1741","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,16]]},"assertion":[{"value":"16 November 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}